FR2364653A1 - Association anti-infectieuse a effet synergique et retard - Google Patents
Association anti-infectieuse a effet synergique et retardInfo
- Publication number
- FR2364653A1 FR2364653A1 FR7628133A FR7628133A FR2364653A1 FR 2364653 A1 FR2364653 A1 FR 2364653A1 FR 7628133 A FR7628133 A FR 7628133A FR 7628133 A FR7628133 A FR 7628133A FR 2364653 A1 FR2364653 A1 FR 2364653A1
- Authority
- FR
- France
- Prior art keywords
- contg
- colistin
- benzathine
- mixts
- benzyl penicillin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010078777 Colistin Proteins 0.000 title abstract 2
- 229960002536 benzathine benzylpenicillin Drugs 0.000 title abstract 2
- BVGLIYRKPOITBQ-ANPZCEIESA-N benzylpenicillin benzathine Chemical compound C=1C=CC=CC=1C[NH2+]CC[NH2+]CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 BVGLIYRKPOITBQ-ANPZCEIESA-N 0.000 title abstract 2
- 229960003346 colistin Drugs 0.000 title abstract 2
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 title abstract 2
- 235000019371 penicillin G benzathine Nutrition 0.000 title abstract 2
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 title abstract 2
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 title abstract 2
- 230000003115 biocidal effect Effects 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
- LPHDUZQZGZACHZ-UHFFFAOYSA-N 1-(2,2-diphenylethenyl)piperidine;hydrochloride Chemical compound Cl.C1CCCCN1C=C(C=1C=CC=CC=1)C1=CC=CC=C1 LPHDUZQZGZACHZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7628133A FR2364653A1 (fr) | 1976-09-20 | 1976-09-20 | Association anti-infectieuse a effet synergique et retard |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7628133A FR2364653A1 (fr) | 1976-09-20 | 1976-09-20 | Association anti-infectieuse a effet synergique et retard |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2364653A1 true FR2364653A1 (fr) | 1978-04-14 |
| FR2364653B1 FR2364653B1 (cs) | 1979-01-12 |
Family
ID=9177821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7628133A Granted FR2364653A1 (fr) | 1976-09-20 | 1976-09-20 | Association anti-infectieuse a effet synergique et retard |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2364653A1 (cs) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984004249A3 (fr) * | 1983-05-03 | 1985-03-14 | Ssm Int Chem Co Ltd | Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires |
| DE4204102A1 (de) * | 1992-02-12 | 1993-08-19 | Kragler Peter | Arzneimittel zur behandlung und/oder prophylaxe von aids und anderen verwandten erkrankungen |
-
1976
- 1976-09-20 FR FR7628133A patent/FR2364653A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984004249A3 (fr) * | 1983-05-03 | 1985-03-14 | Ssm Int Chem Co Ltd | Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires |
| DE4204102A1 (de) * | 1992-02-12 | 1993-08-19 | Kragler Peter | Arzneimittel zur behandlung und/oder prophylaxe von aids und anderen verwandten erkrankungen |
| DE4204102C2 (de) * | 1992-02-12 | 1998-09-24 | Kragler Peter | Arzneimittel zur Behandlung und/oder Prophylaxe von AIDS und anderen verwandten Erkrankungen |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2364653B1 (cs) | 1979-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3650741D1 (de) | Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten. | |
| GR3007251T3 (cs) | ||
| IE40860B1 (en) | Substituted benzamides | |
| DK254588A (da) | Antibiotika | |
| FR2364653A1 (fr) | Association anti-infectieuse a effet synergique et retard | |
| MY104109A (en) | Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives. | |
| ES2055314T3 (es) | Tratamiento de disfuncion leucocitaria con gm-csf. | |
| ES2108680T3 (es) | Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento. | |
| EP0495106A4 (en) | Osteogenesis promoter | |
| JPS6483020A (en) | Medicinal composition for preventing or treating aids | |
| EP0338415A3 (en) | Use of sulphonylureas in the treatment of oedema | |
| FR2155927A1 (en) | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity | |
| ES284914U (es) | Dispositivo para la administracion percutanea de un principio activo. | |
| DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
| KR900701301A (ko) | 후천성 면역 결핍증과 연관된 골수억제증의 치료방법 | |
| FR1604006A (en) | Penicillin derivs | |
| FR2154506A1 (en) | Medicaments contg biotin - as hypoglycaemic agents | |
| ES2035829T3 (es) | Procedimiento para obtener un preparado farmaceutico para el tratamiento de infecciones bactertianas. | |
| ES373657A1 (es) | Un procedimiento para la preparacion de derivados simetri- cos de di-hidrotriazina n-sustituidos. | |
| Olay et al. | Experimental Staphylococcus aureus osteomyelitis treated with fosfomycin and cephazolin: Single and combined therapy. | |
| JPS6438030A (en) | Preventing and treating agent for aids | |
| ES2169117T3 (es) | Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano. | |
| WO1990006116A3 (de) | Mittel zur behandlung von chronisch entzündlichen darmerkrankungen | |
| FR2059965A1 (en) | Antibacterial gamma-lactam of a 7-p-amino-ph | |
| ES8700940A1 (es) | Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |